当前位置: 首页 > 期刊 > 《中国实用医药》 > 2016年第9期
编号:12836916
凋亡相关基因PDCD5在胃癌组织的表达及临床意义(2)
http://www.100md.com 2016年3月25日 《中国实用医药》 2016年第9期
     [2]Liu H, Wang Y, Zhang Y, et al. TFAR19, a Novel Apoptosis-Related Gene Cloned from Human Leukemia Cell Line TF-1, Could Enhance Apoptosis of Some Tumor Cells Induced by Growth Factor Withdrawal. Biochem Biophy Res Comm, 1999, 254(1):203-210.

    [3]谭万龙, 熊林, 郑少斌, 等. 肾透明细胞癌PDCD5表达及与预后的关系. 南方医科大学学报, 2006, 26(9):1316-1318.

    [4]Gao F, Ding L, Zhao M, et al. The clinical significance of reduced Programmed cell death 5 expression in humangastrointestinal stromal tumors. Oncol Rep, 2012, 28(6):2195-2199.

    [5]Tracy CM, Gray A J, Jorge C, et al. Programmed cell deathProtein 5 interacts with the cytosolic chaperonin containing tailless complexPolypeptide 1 (CCT) to regulate β-tubulin folding. J Bio Chem, 2013, 289(7):4490-4502.

    [6]Yang YH, Zhao M, Li WM, et al. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis, 2006, 11(6):993-1001.

    [7]Xu XR, Huang J, Xu ZG, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing geneexpression Profiles of hepatocellular carcinoma with those of corresponding noncancerousliver. Proc Natl Acad Sci USA, 2001, 98(26):15089-15094.

    [8]赵青, 张明川, 梅同华. 程序化死亡因5基因表达与非小细胞肺癌患者对化疗药物敏感性的关系.广东医学, 2013, 34(15): 2331-2333.

    [收稿日期:2015-10-20], 百拇医药(鲍晓蕾 潘留兰 杨丽 徐丽萍)
上一页1 2